Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Extracellular Matrix

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...

The Extracellular Matrix

The Extracellular Matrix

The Bone Matrix

The Bone Matrix

Bone contains a relatively small number of cells entrenched in a matrix of collagen fibers that provide an adherent surface for inorganic salt crystals. Both components of the matrix, organic and inorganic, contribute to the unusual properties of bone. Without collagen, bones would be brittle and shatter easily. Without mineral crystals, bones would flex and provide little support. This can be observed by an experiment: when the minerals of a bone are dissolved by soaking the bone in...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Role of Matrix Metalloproteases in Degradation of ECM

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pediatric extended-release oral formulations: A U.S. market landscape analysis.

Journal of pharmaceutical sciences·2026

Same author

Targeting the NAD<sup>+</sup>-PARP1-XRCC1 axis in ALS.

Trends in molecular medicine·2026

Same author

A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer.

Acta biomaterialia·2026

Same author

Peripheral vaccination-induced brain-resident memory CD8+ T cells durably protect mice against intracranial malignancy.

The Journal of clinical investigation·2026

Same author

The Versatile Role of GDF5 in Chondrogenic Progenitor Cell-mediated Cartilage Regeneration via a Hyaluronic Acid-fibrin IPN Hydrogel Platform.

Pharmaceutical research·2026

Same author

Quantitative Proteomic Profiling of Bronchoalveolar Lavage-Derived Extracellular Vesicles in a Murine Asthma Model.

Chemical research in toxicology·2026

Search research articles

Related Experiment Video

Updated: Apr 2, 2026

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

Chemically modified RNA activated matrices enhance bone regeneration.

Satheesh Elangovan¹, Behnoush Khorsand², Anh-Vu Do²

¹Department of Periodontics, University of Iowa College of Dentistry, Iowa City, IA, United States.

Journal of Controlled Release : Official Journal of the Controlled Release Society

|September 30, 2015

Summary

Chemically modified RNA (cmRNA) complexed with polyethylenimine (PEI) shows promise for bone regeneration. This gene therapy approach enhanced bone repair in vivo, offering a potential alternative to protein delivery for bone defect treatment.

Keywords:

Bone morphogenetic protein-2 Bone regeneration Chemically modified RNA Gene delivery Plasmid DNA Polyethylenimine

More Related Videos

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

Related Experiment Videos

Last Updated: Apr 2, 2026

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

Area of Science:

Biomaterials Science
Regenerative Medicine
Gene Therapy

Background:

Predictable bone regeneration requires improved therapeutic strategies.
Non-viral gene therapy offers a safer, more efficient alternative to protein delivery for growth factors.
Chemically modified ribonucleic acid (cmRNA) presents a novel platform for gene delivery.

Purpose of the Study:

To evaluate the transfection efficiency, cytotoxicity, and osteogenic potential of cmRNA encoding BMP-2 complexed with polyethylenimine (PEI).
To compare the in vivo bone regenerative capacity of PEI-cmRNA (BMP-2) with PEI-plasmid DNA (BMP-2).
To establish a proof of concept for using non-viral vectors with cmRNA for bone regeneration.

Main Methods:

Fabrication of polyplexes (PEI-cmRNA and PEI-plasmid DNA) at an N/P ratio of 10.
Assessment of transfection efficiency in human bone marrow stromal cells (BMSCs).
Validation of osteogenic potential by measuring bone-specific gene expression (osteocalcin, alkaline phosphatase) and matrix deposition.
Evaluation of in vivo bone regeneration using a rat calvarial bone defect model.

Main Results:

PEI-cmRNA demonstrated effective transfection and osteogenic potential in BMSCs.
PEI-cmRNA (BMP-2)-activated matrices significantly enhanced bone regeneration compared to PEI-plasmid DNA (BMP-2) in a rat calvarial defect model.
The study confirmed the feasibility of using cmRNA-based gene therapy for bone regeneration.

Conclusions:

Scaffolds loaded with non-viral vectors carrying cmRNA encoding osteogenic proteins are a potent tool for stimulating bone regeneration.
This approach holds significant potential for clinical translation in treating bone defects.
cmRNA-based gene therapy offers a promising alternative to traditional methods for bone regeneration.